📰 Breaking News: Lessons Learnt & Insights from DSTBTD Restructuring Plan

Appointment of liquidators (MVL)

Vimela Therapeutics Limited enters members' voluntary liquidation

active Company no. 13611487 Published 10 July 2026

In short: Vimela Therapeutics Limited (company no. 13611487) entered members' voluntary liquidation, a solvent and planned closure, according to a Appointment of liquidators (MVL) notice published in The London Gazette on 10 July 2026. The office holder is James Hopkirk (IP No. 21150) of Kreston Reeves LLP, 2nd Floor Maritime Place, Quayside, Chatham Maritime, Kent, ME4 4QZ, appointed 30 June 2026. The company's business: research and experimental development on biotechnology, trading from The Cambridge Partnership The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, Cambridgeshire, CB22 3FH.

The notice announces the appointment of James Hopkirk of Kreston Reeves LLP as liquidator for VIMELA THERAPEUTICS LIMITED in a members voluntary liquidation.

Notice details

Company
VIMELA THERAPEUTICS LIMITED
Company number
13611487
Nature of business
Research and experimental development on biotechnology
Type of liquidation
Members Voluntary Liquidation
Registered office
The Cambridge Partnership The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, CB22 3FH
Principal trading address
The Cambridge Partnership The Dorothy Hodgkin Building, Babraham Research Campus, Cambridge, Cambridgeshire, CB22 3FH
Liquidator
James Hopkirk (IP No. 21150) of Kreston Reeves LLP, 2nd Floor Maritime Place, Quayside, Chatham Maritime, Kent, ME4 4QZ
Contact
Mansi Thawani, 01634 899800, [email protected]
Appointed by
Members
Date of appointment
30 June 2026

What this notice means

A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

Read more: What is Liquidation?.

All notices for Vimela Therapeutics Limited

3 Gazette notices on record for company no. 13611487, newest first. The full history, with last filed accounts, is on the Vimela Therapeutics Limited company record.

  1. Resolution for winding up (MVL) 10 Jul 2026
  2. Notices to creditors (MVL) 10 Jul 2026

How does this notice affect you?

Choose what applies and we'll point you at the right next step.

Would rather just talk? 020 7720 8000

Related guidance

Free, practical guides from K2 on what this kind of notice means for directors.

More liquidation notices

← Back to all notices

Frequently asked questions

Is Vimela Therapeutics Limited in financial difficulty?

No — this is a solvent process. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The London Gazette published a Appointment of liquidators (MVL) for Vimela Therapeutics Limited (company no. 13611487) on 10 July 2026.

What does a Appointment of liquidators (MVL) mean?

A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

Who is dealing with the liquidation?

The office holder named in the notice: James Hopkirk (IP No. 21150) of Kreston Reeves LLP, 2nd Floor Maritime Place, Quayside, Chatham Maritime, Kent, ME4 4QZ, appointed 30 June 2026. Creditors, employees and anyone holding goods or money belonging to the company should contact them directly, quoting the company number.

Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.